Correlation Between Microsoft and Telo Genomics

Can any of the company-specific risk be diversified away by investing in both Microsoft and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Microsoft and Telo Genomics Corp, you can compare the effects of market volatilities on Microsoft and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Telo Genomics.

Diversification Opportunities for Microsoft and Telo Genomics

-0.27

Correlation Coefficient

Microsoft  Telo Genomics

Very good diversification

The 3 months correlation between Microsoft and Telo is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Microsoft i.e., Microsoft and Telo Genomics go up and down completely randomly.

Pair Corralation between Microsoft and Telo Genomics

Given the investment horizon of 90 days Microsoft is expected to generate 0.19 times more return on investment than Telo Genomics. However, Microsoft is 5.32 times less risky than Telo Genomics. It trades about 0.02 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about -0.02 per unit of risk. If you would invest  44,807  in Microsoft on September 19, 2024 and sell it today you would earn a total of  639.00  from holding Microsoft or generate 1.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Microsoft  vs.  Telo Genomics Corp

Microsoft

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Telo Genomics Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telo Genomics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Microsoft and Telo Genomics

The main advantage of trading using opposite Microsoft and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.

The idea behind Microsoft and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.